Return to search

GrayMatters Health inks $10m Series A

GrayMatters Health, a developer of digital self-neuromodulation therapeutics for mental disorders, has raised $10 million in Series A financing.

GrayMatters Health, a developer of digital self-neuromodulation therapeutics for mental disorders, has raised $10 million in Series A financing. Otsuka Medical Devices Co. Ltd led the round.

Source: Press Release